At present, it is not clear whether AD is better suited to a continuum model of long-term asymptomatic prostate cancer or to a risk model in which asymptomatic amyloid-positive and tau-positive persons are at risk and persons with a clinical phenotype are in a disease state (similar to a cancer state). Here, MAPT is linked to Alzheimer disease.